Raphael Pharmaceutical Inc. (RAPH) SEC Filings — 2024
9 SEC filings for Raphael Pharmaceutical Inc. (RAPH) in 2024.
Filings
- Raphael Pharma to Acquire Bio-Gen Innovations — 8-K · Dec 30, 2024
- Raphael Pharmaceutical Files Q3 2024 10-Q — 10-Q · Nov 14, 2024
- Raphael Pharmaceutical Files S-1 for IPO — S-1 · Sep 13, 2024
- Raphael Pharmaceutical Appoints New Auditor — 8-K · Sep 11, 2024
- Raphael Pharmaceutical Files Q2 2024 10-Q — 10-Q · Aug 12, 2024
- Raphael Pharmaceutical Changes Executive Offices to Israel — 8-K · Jun 26, 2024
- Raphael Pharmaceutical Inc. Files 10-Q for Period Ended March 31, 2024 — 10-Q · May 15, 2024
- Raphael Pharmaceutical to Acquire Bio-Gen Innovations — 8-K · May 2, 2024
- Raphael Pharmaceutical Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 28, 2024